Downregulation of cell‐free miR‐198 as a diagnostic biomarker for lung adenocarcinoma‐associated malignant pleural effusion

• Published in: International journal of cancer Vol. 133; no. 3; pp. 645 - 652
• Main Authors: Han, Hye‐Suk, Yun, Jieun, Lim, Sung‐nam, Han, Joung‐Ho, Lee, Ki Hyeong, Kim, Seung Taik, Kang, Min‐Ho, Son, Seung‐Myoung, Lee, Yong‐Moon, Choi, Song‐Yi, Yun, Seok Joong, Kim, Wun‐Jae, Lee, Ok‐Jun
• Format: Journal Article
• Language: English
• Published: Hoboken, NJ Wiley-Blackwell 01.08.2013; Wiley Subscription Services, Inc
• Subjects: Adenocarcinoma - diagnosis; Adenocarcinoma - genetics; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Antigens, Neoplasm - blood; Biological and medical sciences; Biomarkers; Biomarkers, Tumor - blood; Biomarkers, Tumor - genetics; Cancer; Carcinoembryonic Antigen - blood; CEA; Confidence intervals; CYFRA 21‐1; Diagnosis, Differential; Down-Regulation; Female; Humans; Keratin-19 - blood; lung adenocarcinoma; Lung cancer; Lung Neoplasms - diagnosis; Lung Neoplasms - genetics; Male; Medical sciences; MicroRNAs - blood; Middle Aged; miR‐198; Multiple tumors. Solid tumors. Tumors in childhood (general aspects); Oligonucleotide Array Sequence Analysis; Pediatrics; pleural effusion; Pleural Effusion, Malignant - diagnosis; Pleural Effusion, Malignant - genetics; Pneumology; ROC Curve; Tumors; Tumors of the respiratory system and mediastinum; Young Adult; Lung disease; Respiratory disease; Lung cancer; lung adenocarcinoma; Pleural effusion; Biological marker; Cytokeratin 19; Malignant tumor; Bronchopulmonary adenocarcinoma; Malignant pleural effusion; Cancerology; miR-198; Pleurisy; Pleural disease; Bronchus disease; Diagnosis; Cell free system; CYFRA 21-1; CEA; Cancer
• ISSN: 0020-7136; 1097-0215
• DOI: 10.1002/ijc.28054

Circulating cell‐free microRNAs (miRNAs) are potential cancer biomarkers. The aim of this study was to identify miRNAs that are differentially expressed between benign pleural effusion (BPE) and lung adenocarcinoma‐associated malignant pleural effusion (LA‐MPE). The expression level of cell‐free miRNA was investigated in 107 patients with pleural effusion. Microarrays were used to screen 160 miRNAs in a discovery set comprising 20 effusion samples (ten BPEs and ten LA‐MPEs). Real‐time quantitative reverse transcription polymerase chain reaction (qRT‐PCR) was used to validate the profiling results obtained for the discovery set and those obtained for a validation set comprising 42 BPEs and 45 LA‐MPEs. The area under the receiver operating characteristic curve (AUC) was used to evaluate the diagnostic performance of the identified miRNAs and other common tumor markers, such as carcinoembryonic antigen (CEA) and cytokeratin fragment (CYFRA) 21‐1. Microarray profiling showed that miR‐198 was significantly downregulated in LA‐MPE compared with BPE (p = 0.002). The miRNA microarray analysis results were confirmed by qRT‐PCR (p < 0.001) using the validation set. The AUCs for miR‐198, CEA and CYFRA 21‐1 in the validation set were 0.887, 0.898 and 0.836, respectively. The diagnostic performance of miR‐198 was comparable with that of CEA, but better than that of CYFRA 21‐1. The AUC for all three markers combined was 0.926 (95% confidence interval, 0.843–0.973) with a sensitivity of 89.2% and a specificity of 85.0%. The present study suggests that cell‐free miR‐198 from patients with pleural effusion might have diagnostic potential for differentiating LA‐MPE from BPE. What's new? Short bits of regulatory RNA called miRNAs circulate in the blood, and they sometimes prove useful for diagnosing cancers. This study investigated whether miRNAs could help distinguish between benign and cancer‐related fluid build‐up in the lungs. One miRNA, miR‐198, was expressed much less in samples from patients with the pre‐cancerous condition than those whose fluid accumulation was benign. When they quantified miR‐198's predictive ability, the authors found that it performed as well or better than two common cancer markers, CEA and CYFRA. The newly identified miRNA, therefore, could be quite handy for diagnosing lung adenocarcinomas.